134 related articles for article (PubMed ID: 7850257)
1. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
[TBL] [Abstract][Full Text] [Related]
2. [Mucoregulatory therapy in secreting disease of the middle ear].
Bonci M; Bozzi A
Minerva Med; 1994 Mar; 85(3):83-7. PubMed ID: 8196848
[TBL] [Abstract][Full Text] [Related]
3. Elastase causes secretory discharge in bronchi of hamsters with elastase-induced secretory cell metaplasia.
Breuer R; Christensen TG; Lucey EC; Bolbochan G; Stone PJ; Snider GL
Exp Lung Res; 1993; 19(2):273-82. PubMed ID: 8467766
[TBL] [Abstract][Full Text] [Related]
4. Flurbiprofen does not affect elastase-induced bronchial secretory cell metaplasia in hamsters.
Nields HM; Snider GL; Christensen TG
Eur Respir J; 1991 Feb; 4(2):205-9. PubMed ID: 2044737
[TBL] [Abstract][Full Text] [Related]
5. The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride.
Caramia G; Gagliardini R; Ruffini E; Osimani P; Nobilini A
J Int Med Res; 1995; 23(4):284-93. PubMed ID: 7589772
[TBL] [Abstract][Full Text] [Related]
6. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
[TBL] [Abstract][Full Text] [Related]
8. Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations.
Lucey EC; Stone PJ; Christensen TG; Breuer R; Calore JD; Snider GL
Am Rev Respir Dis; 1986 Sep; 134(3):471-5. PubMed ID: 3530070
[TBL] [Abstract][Full Text] [Related]
9. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
Braga PC; Bossi R; Allegra L
Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
[TBL] [Abstract][Full Text] [Related]
11. [Local immunity following treatment with S-carboxymethylcysteine-lysine in tracheotomy patients].
Carlevato MT; Battaglio S; Galeazzi E; Bussi M
Acta Otorhinolaryngol Ital; 1992; 12(2):127-34. PubMed ID: 1414321
[TBL] [Abstract][Full Text] [Related]
12. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
13. Stimulation of Cl- secretion by the mucoactive drug S-carboxymethylcysteine-lysine salt in the isolated rabbit trachea.
Colombo B; Turconi P; Daffonchio L; Fedele G; Omini C; Cremaschi D
Eur Respir J; 1994 Sep; 7(9):1622-8. PubMed ID: 7995391
[TBL] [Abstract][Full Text] [Related]
14. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
15. [Mucociliary clearance function and medicamentous modification].
Konrad F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Sep; 31(7):404-8. PubMed ID: 8991466
[TBL] [Abstract][Full Text] [Related]
16. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
Casali L; Rampulla C; Rossi A
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
[TBL] [Abstract][Full Text] [Related]
17. Reversible pancreatic elastase-induced bronchial secretory cell metaplasia in the rat.
Nields HM; Snider GL; Breuer R; Christensen T
Exp Pathol; 1991; 41(4):185-93. PubMed ID: 2070841
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1-protease inhibitor moderates human neutrophil elastase-induced emphysema and secretory cell metaplasia in hamsters.
Stone PJ; Lucey EC; Virca GD; Christensen TG; Breuer R; Snider GL
Eur Respir J; 1990 Jun; 3(6):673-8. PubMed ID: 2379577
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of pharmacologic and non-pharmacologic methods of restoring bronchial patency].
Lunichkina IV; Solopov VN
Klin Med (Mosk); 1989 Jun; 67(6):109-11. PubMed ID: 2779144
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic activity of human neutrophil elastase and porcine pancreatic trypsin causes bronchial secretory cell metaplasia in hamsters.
Breuer R; Lucey EC; Stone PJ; Christensen TG; Snider GL
Exp Lung Res; 1985; 9(1-2):167-75. PubMed ID: 3905365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
